Document is current
Any future updates will be listed below
-
Authors
Hernández-López, Patricia
van Diest, Eline
Brazda, Peter https://orcid.org/0000-0002-0215-1692
Heijhuurs, Sabine
Meringa, Angelo
Hoorens van Heyningen, Lauren https://orcid.org/0000-0002-6025-3398
Riillo, Caterina
Schwenzel, Caroline
Zintchenko, Marina https://orcid.org/0000-0001-9717-0732
Johanna, Inez
Nicolasen, Mara J. T.
Cleven, Astrid
Kluiver, Thomas A. https://orcid.org/0000-0003-2224-480X
Millen, Rosemary
Zheng, Jiali
Karaiskaki, Froso
Straetemans, Trudy
Clevers, Hans https://orcid.org/0000-0002-3077-5582
de Bree, Remco
Stunnenberg, Hendrik G. https://orcid.org/0000-0002-0066-1576
Peng, Weng Chuan https://orcid.org/0000-0001-5467-5458
Roodhart, Jeanine
Minguet, Susana https://orcid.org/0000-0001-8211-5538
Sebestyén, Zsolt
Beringer, Dennis X. https://orcid.org/0000-0002-5986-1134
Kuball, Jürgen https://orcid.org/0000-0002-3914-7806
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding
- License Information
-
More Information
Article History
Received: 29 December 2022
Accepted: 29 September 2023
First Online: 27 November 2023
Competing interests
: J.K. was a shareholder of Gadeta. J.K., Z.S., E.v.D. and D.X.B. are inventors on patents with γδ TCR-related topics. J.K., Z.S., D.X.B., P.H.-L., A.M. and A.C. are inventors on patents with CD277-related topics. For the full disclosure of H.C., see . J.R. has advisory roles for Merck-Serono, Pierre Fabre, Servier, BMS, Roche, Bayer and GSK (all payments to the institution) and institutional scientific grants from Bristol Myers Squibb, Merck, Delphi, HUB4 Organoids, Cleara, Pierre Fabre, Servier, Xilis and GSK. J.R. is also a board member for the Foundation Hubrecht Organoid Biobank. All other authors have no competing interests.
